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CORRESPONDENCE
Pseudohypercreatininaemia in
two patients caused by
monoclonal IgM interference
with enzymatic assay of
creatinine
INTRODUCTION
Creatinine is released into the blood follow-
ing non-enzymatic hydrolysis of creatine in
skeletal muscle, and excreted into urine
depending on glomerular ﬁltration. The
serum creatinine concentration is widely
used as a marker of glomerular function
because it increases in patients with
decreased glomerular ﬁltration rate (GFR).
Although GFR is costly to measure, an esti-
mated GFR (eGFR) can be calculated from
the serum creatinine concentration. Since
2006, laboratories have calculated eGFR
values using the isotope dilution mass spec-
trometry traceable modiﬁcation of diet in
renal disease equation.1 This standardisa-
tion allows direct comparison of creatinine
and eGFR results from different laborator-
ies. Reporting of eGFR is a signiﬁcant
advance, but it should be remembered that
results are affected by interferences affect-
ing the creatinine assay.
Serum creatinine was initially measured
for clinical purposes using alkaline picrate
( Jaffé reaction),2 but this method is affected
by numerous interferents, including biliru-
bin, ketones, protein and non-creatinine
chromogens.3 Enzymatic assays were later
introduced, which are less susceptible to
interference3 and more speciﬁc being
unaffected by non-creatinine chromogens.4
However, interference has been reported
from 5-ﬂuorocytosine, ethamsylate, dopa-
mine, dobutamine, nitromethane, creatine,
sarcosine and ascorbic acid. Hummel et al5
reported positive interference in
enzymatic creatinine measurement caused
by monoclonal IgM in three patients with
Waldenström’s macroglobulinaemia. IgM
can precipitate and interfere in the detection
step of the reaction. This interference can
be avoided by ultraﬁltration to remove
protein before measuring creatinine. At the
time of this publication, most clinical labora-
tories were measuring creatinine using alka-
line picrate assays. However, since the
introduction of eGFR, reporting the use of
enzymatic assays has become more wide-
spread. It, therefore, seems timely to illus-
trate this problem by describing two cases
recently referred to the renal service.
CASE REPORT 1
A 71-year-old female was referred by her
general practitioner (GP) to a satellite
nephrology outpatient clinic for investiga-
tion of a serum creatinine of 257 μmol/L
(Siemens Advia enzymatic assay). She was
well, and there was no signiﬁcant past
medical or renal history. She was not
taking any prescribed medications, but did
take evening primrose oil, cod liver oil,
glucosamine and garlic capsules. Previous
blood tests had shown normal glucose
and bilirubin concentrations.
Initial investigations were all normal.
However, capillary electrophoresis of
serum proteins (Sebia UK), showed a dis-
crete monoclonal peak at a concentration
of 9 g/L. Immunoﬁxation (Sebia UK)
showed that this was IgM kappa. Most of
the IgM present was monoclonal. No
monoclonal free light chains were
detected in the urine. To determine the
cause of the increased serum creatinine,
she was invited to the central renal unit
for a renal biopsy. Prebiopsy blood tests
showed a serum creatinine of 73 μmol/L
(Abbott Architect 3 enzymatic assay),
and a second specimen analysed by the
same method showed a creatinine of
70 μmol/L. The apparent decrease in cre-
atinine concentration was initially pre-
sumed to represent an episode of acute
kidney injury (AKI), of unknown cause,
from which, the patient had completely
recovered. She was not biopsied.
Following discharge, she remained well,
and after 2 weeks, attended the satellite
nephrology outpatient clinic for review.
The serum creatinine was again increased at
216 μmol/L (Siemens Advia enzymatic
assay). To investigate the discrepancy in
results, a serum specimen from the patient
was sent to three different laboratories, and
creatinine measured by three different
methods viz Siemens Advia enzymatic assay,
Abbott Architect 3 enzymatic assay and
picric acid Jaffé (O’Leary) reaction. The
results were as shown below in table 1.
GFR was measured deﬁnitively by
iohexol clearance and found to be
63 mL/min/1.73 m2. At this stage, it was
clear that the serum creatinine
concentration, as measured by the
Siemens Advia enzymatic assay, was arte-
factually increased.
CASE REPORT 2
A 63-year-old male was referred by his
GP to a different satellite general nephrol-
ogy outpatient clinic for investigation of
abnormal renal function. Serum creatinine
had been above 300 μmol/L on two occa-
sions (Siemens Advia enzymatic assays).
There were no symptoms or signs of renal
or systemic disease.
To further investigate this possible AKI,
serum protein electrophoresis was per-
formed, which showed an IgM kappa para-
protein at a concentration of 15 g/L. Total
IgM was increased at 20 g/L (0.5–2.0), and
both IgA and IgG were low at 0.41 g/L
(0.8–4.0) and 5.1 g/L (6.0–16), respectively.
Capillary electrophoresis of serum proteins
(Sebia UK) showed a discrete monoclonal
peak. Immunoﬁxation (Sebia UK) showed
that this was IgM kappa. The IgM present
was entirely monoclonal. Urine immuno-
ﬁxation detected free kappa monoclonal
light chains. A bone marrow biopsy showed
B cell lymphoma, in keeping with lympho-
plasmacytic lymphoma. Subsequently, the
patient attended the renal unit for a renal
biopsy. However, prebiopsy blood tests
showed creatinine 89 μmol/L (Abbott
Architect 3 enzymatic assay). This was con-
ﬁrmed by analysis of a second specimen,
which showed creatinine 84 μmol/L.
A serum specimen was assayed simul-
taneously by Siemens Advia and Abbott
Architect 3 enzymatic assays. The results
were as shown below in table 2.
The discrepancy in creatinine measure-
ments was further investigated by measure-
ment of serum cystatin C concentration,
which was normal at 0.90 mg/L (reference
range <1.4). An eGFR calculated using
cystatin C was normal at 105 mL/min/
1.73 m2.6 A renal biopsy was no longer
considered necessary.
DISCUSSION
In both these cases, the Siemens Advia
enzymatic assay consistently gave artefac-
tually high creatinine results.
Table 1 Creatinine and eGFR results obtained from a single sample being analysed by three
different methods—Siemens Advia and Abbott Architect 3 enzymatic assays, and picric acid
Jaffé reaction
Creatinine (μmol/L) eGFR
Siemens Advia enzymatic assay 257 16
Abbott Architect 3 enzymatic assay 75/73 >60/>60
Picric acid Jaffé 82 >60
eGFR, estimated glomerular filtration rate.
J Clin Pathol Month 2015 Vol 0 No 0 1
PostScript
 JCP Online First, published on June 9, 2015 as 10.1136/jclinpath-2015-203064
Copyright Article author (or their employer) 2015. Produced by BMJ Publishing Group Ltd under licence. 
group.bmj.com on June 12, 2015 - Published by http://jcp.bmj.com/Downloaded from 
Compared with the older, alkaline
picrate methods, enzymatic assays for cre-
atinine have less frequently been reported
to be affected by interference, but there
have been reports of interference by IgG7
and IgM.5 In the cases reported here, the
discrepancies in creatinine concentrations
resulted from pseudohypercreatininaemia,
which we believe was caused by positive
interference by monoclonal IgM. In the
previously published cases,5 IgM concen-
trations ranged from 7.8 to 44 g/L,
whereas the concentrations in the two
cases reported here were both at the
lower end of this range. This suggests that
even low-level IgM paraproteinaemia,
such as that present in monoclonal gam-
mopathy of uncertain signiﬁcance, can
interfere signiﬁcantly with some enzym-
atic assays. It is not known why this inter-
ference was conﬁned to the Siemens
Advia method, but other authors have
observed that some paraproteins are sus-
ceptible to precipitation at a particular
assay pH.7
Given that IgM paraproteinaemia is
not uncommon, and enzymatic assays
are now widely used, clinicians are
likely to encounter this interference.
Pseudohypercreatininaemia caused by
IgM paraproteinaemia should be con-
sidered when investigating the cause of
an unexplained high serum creatinine
concentration, so that inappropriate
investigation and diagnostic conun-
drums can be avoided.
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